{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:34:06Z","timestamp":1786653246824,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2230-8210.176360","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T14:32:49Z","timestamp":1455546769000},"page":"157","source":"Crossref","is-referenced-by-count":10,"title":["Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects"],"prefix":"10.4103","volume":"20","author":[{"given":"Neha","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VP","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bhavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ArunS","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RV","family":"JayKumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugha","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.176360-1","first-page":"783","volume-title":"Remission of Graves' disease during anti-thyroid drug therapy.Time to reconsider the mechanism?","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.176360-2","first-page":"448","volume-title":"Predictors of long-term remission in patients with Graves' disease: A single center experience","author":"Anagnostis","year":"2013","journal-title":"Endocrine"},{"key":"key-10.4103\/2230-8210.176360-3","first-page":"690","volume-title":"Remission of Grave's disease after oral anti-thyroid drug treatment","author":"Ishtiaq","year":"2009","journal-title":"J Coll Physicians Surg Pak"},{"key":"key-10.4103\/2230-8210.176360-4","first-page":"369","volume-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"key-10.4103\/2230-8210.176360-5","first-page":"583","volume-title":"Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.176360-6","first-page":"689","volume-title":"Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease","author":"Schleusener","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key-10.4103\/2230-8210.176360-7","first-page":"98","volume-title":"Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease","author":"Feldt-Rasmussen","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.176360-8","first-page":"1083","volume-title":"Low remission after therapy for Graves disease.Possible relation of dietary iodine with antithyroid therapy results","author":"Wartofsky","year":"1973","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.176360-9","first-page":"643","volume-title":"Prediction of relapse in drug-treated Graves' disease using thyroid stimulation indices","author":"Ikenoue","year":"1991","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.176360-10","first-page":"118","volume-title":"Prediction of remission in Graves' disease treated with long-term carbimazole therapy: Evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators","author":"Prakash","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"key-10.4103\/2230-8210.176360-11","first-page":"57","volume-title":"Factors predicting treatment failure in patients treated with iodine-131 for Graves' disease","author":"Manohar","year":"2013","journal-title":"World J Nucl Med","ISSN":"https:\/\/id.crossref.org\/issn\/1450-1147","issn-type":"print"},{"key":"key-10.4103\/2230-8210.176360-12","first-page":"419","volume-title":"Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010","author":"Mohlin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.176360-13","first-page":"1038","volume-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.176360-14","first-page":"1719","volume-title":"Predictors of early remission of hyperthyroidism in children","author":"Glaser","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.176360-15","first-page":"1047","volume-title":"Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease","author":"Quadbeck","year":"2005","journal-title":"Thyroid"},{"key":"key-10.4103\/2230-8210.176360-16","doi-asserted-by":"crossref","unstructured":"Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, et al. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the treatment of hyperthyroidism with antithyroid drugs. Clin Endocrinol (Oxf) 1998;49:451-7.","DOI":"10.1046\/j.1365-2265.1998.00554.x"},{"key":"key-10.4103\/2230-8210.176360-17","first-page":"157","volume-title":"Prediction of remission in Graves' disease after thionamide therapy by technetium-99m early uptake","author":"Misaki","year":"1991","journal-title":"Kaku Igaku"},{"key":"key-10.4103\/2230-8210.176360-18","first-page":"1101","volume-title":"Prediction of relapse in hyperthyroid Graves' disease","author":"McGregor","year":"1980","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.176360-19","first-page":"467","volume-title":"TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs","author":"Okamoto","year":"2006","journal-title":"Endocr J"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:07Z","timestamp":1786649647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2230-8210.176360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["176360"],"URL":"https:\/\/doi.org\/10.4103\/2230-8210.176360","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}